Cargando…

Urokinase Attenuates Pulmonary Thromboembolism in an Animal Model by Inhibition of Inflammatory Response

Inflammatory response is an important determining factor for the mortality of patients with pulmonary thromboembolism. Inflammatory mediators can promote thrombus formation and increase hemodynamic instability. Urokinase is a commonly used drug for the treatment of PTE. The effect of urokinase on in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Ying, Zhang, Zhirong, Cai, Danli, Kuang, Jing, Jin, Shuifang, Zhu, Chen, Shen, Yingying, Feng, Wen, Ying, Songmin, Wang, Lingcong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323506/ https://www.ncbi.nlm.nih.gov/pubmed/30671487 http://dx.doi.org/10.1155/2018/6941368

Ejemplares similares

Aspirin modulates the inflammatory response in a thrombus-stimulated LMVEC model
por: Wang, Lingcong, et al.
Publicado: (2018)

Panax notoginseng protects the rat brain function from traumatic brain injury by inhibiting autophagy via mammalian targeting of rapamycin
por: Shi, Ying, et al.
Publicado: (2021)

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
por: Luo, Shengyuan, et al.
Publicado: (2022)

cRGD Urokinase Liposomes for Thrombolysis in Rat Model of Acute Pulmonary Microthromboembolism
por: Liang, Chunting, et al.
Publicado: (2022)

MicroRNA 449a can Attenuate Protective Effect of Urokinase Against Pulmonary Embolism
por: Zhu, Ran, et al.
Publicado: (2022)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022)

Urokinase-loaded cyclic RGD-decorated liposome targeted therapy for in-situ thrombus of pulmonary arteriole of pulmonary hypertension
por: Li, Jingtao, et al.
Publicado: (2022)

Comparison of urokinase and reteplase thrombolytic treatment in patients with high-risk pulmonary embolism
por: Zhang, Yi, et al.
Publicado: (2019)

Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial
por: Wang, Chen, et al.
Publicado: (2009)

Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism
por: Neto-Neves, Evandro M, et al.
Publicado: (2013)

Trauma-induced pulmonary thromboembolism: What's update?
por: Mi, Yu-Hong, et al.
Publicado: (2022)

The Receptor for Urokinase Regulates TLR2 Mediated Inflammatory Responses in Neutrophils
por: Liu, Gang, et al.
Publicado: (2011)

Urokinase System in Pathogenesis of Pulmonary Fibrosis: A Hidden Threat of COVID-19
por: Shmakova, Anna A., et al.
Publicado: (2023)

Efficacy and Safety of Bronchial Artery Embolization on Hemoptysis in Chronic Thromboembolic Pulmonary Hypertension: A Pilot Prospective Cohort Study
por: Yang, Suqiao, et al.
Publicado: (2019)

Isoliquiritigenin Attenuates Monocrotaline-Induced Pulmonary Hypertension via Inhibition of the Inflammatory Response and PASMCs Proliferation
por: Jin, Haifeng, et al.
Publicado: (2019)

Baicalein attenuates OVA-induced allergic airway inflammation through the inhibition of the NF-κB signaling pathway
por: Xu, Tingting, et al.
Publicado: (2019)

Urokinase and macrophages in tumour angiogenesis.
por: Hildenbrand, R., et al.
Publicado: (1995)

Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis
por: Lee, Ji-Hye, et al.
Publicado: (2014)

Description, Staging and Quantification of Pulmonary Artery Angiophagy in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
por: Perros, Frédéric, et al.
Publicado: (2020)

Changes in Inflammatory Markers in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty
por: Magoń, Wojciech, et al.
Publicado: (2022)

Terminalia catappa attenuates urokinase-type plasminogen activator expression through Erk pathways in Hepatocellular carcinoma
por: Yeh, Chao-Bin, et al.
Publicado: (2014)

LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT(1)R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension
por: Su, Hua, et al.
Publicado: (2018)

A Role for Caveolin and the Urokinase Receptor in Integrin-mediated Adhesion and Signaling
por: Wei, Ying, et al.
Publicado: (1999)

Screening of potential hub genes in pulmonary thromboembolism
por: Lu, Yan, et al.
Publicado: (2022)

Pulmonary Thromboembolectomy for Acute Pulmonary Thromboembolism
por: Yi, Inho, et al.
Publicado: (2011)

Inhibition of urokinase-type plasminogen activator expression by dihydroartemisinin in breast cancer cells
por: ZHANG, SHUQUN, et al.
Publicado: (2014)

The Urokinase/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors
por: Rossi, Francesca Wanda, et al.
Publicado: (2016)

Involvement of the Serine Protease Inhibitor, SERPINE2, and the Urokinase Plasminogen Activator in Cumulus Expansion and Oocyte Maturation
por: Lu, Chung-Hao, et al.
Publicado: (2013)

Urokinase-type plasminogen activator: a new target for male contraception?
por: Qin, Ying, et al.
Publicado: (2015)

Chronic Thromboembolic Pulmonary Hypertension – What Have We Learned From Large Animal Models
por: Stam, Kelly, et al.
Publicado: (2021)

A case report of pulmonary thromboembolism following allergic bronchopulmonary aspergillosis
por: Pan, Ying, et al.
Publicado: (2020)

Pulmonary Thromboembolism in COVID-19: Venous Thromboembolism or Arterial Thrombosis?
por: Cavagna, Enrico, et al.
Publicado: (2020)

The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review
por: Tucker, Torry A., et al.
Publicado: (2021)

Pulmonary artery intimal sarcoma mimicking pulmonary thromboembolism: A case report
por: Li, Ying-Chun, et al.
Publicado: (2021)

Massive Pulmonary Thromboembolism and Stroke
por: Naidoo, Poobalan, et al.
Publicado: (2011)

Chronic Thromboembolic Pulmonary Hypertension
por: Wittine, Lara M., et al.
Publicado: (2010)

Chronic thromboembolic pulmonary hypertension
por: Schölzel, B. E., et al.
Publicado: (2014)

LUNG CANCER AND PULMONARY THROMBOEMBOLISM
por: Cukic, Vesna, et al.
Publicado: (2015)

Chronic thromboembolic pulmonary hypertension
por: Correale, Michele, et al.
Publicado: (2015)

Chronic thromboembolic pulmonary hypertension
por: Kim, Nick H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mvege2dicd27hqm9n651t6do7s